Confirmed on the employer's own hiring board on Nov 16, 2026. First seen by Alion on Nov 16, 2026. Amylyx scores A on the Alion truth index.
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS).
Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine’s toughest problems, we encourage you to read the opportunity below and apply.
The Opportunity
Amylyx is seeking a highly experienced Senior Director, CMC Technical Development to provide strategic and technical leadership across Amylyx’s clinical and late-stage pipeline, including the Phase III synthetic peptide avexitide, Phase I antisense oligonucleotide AMX0114, and Phase 2 small molecule AMX0035. This leader will be responsible for driving phase-appropriate technical development including drug substance and drug product process development, product characterization, formulation selection, process scale-up, and validation readiness in partnership with internal CMC functions and external CDMOs.
The ideal candidate will combine strategic leadership, deep scientific and technical expertise, strong partnership skills, and the willingness to contribute hands-on when needed in a small, fast-moving biotech environment. This role reports to the Senior Vice President, CMC and External Manufacturing.
Responsibilities
Strategic Technical Leadership:
- Lead technical development across Amylyx’s pipeline, ensuring plans are scientifically rigorous, phase-appropriate, and aligned with clinical, regulatory, quality, supply, and business objectives.
- Serve directly or through direct reports as the Technical Development lead on CMC asset teams, accountable to provide clear technical requirements, risks, timelines, decision options, regulatory filing materials, and clinical supplies.
- Provide input into target product profiles ensuring technical feasibility and translating into critical quality attributes and critical process parameters.
- Partner with CMC Team Strategy lead(s) to integrate technical development plans into overall asset strategies.
- Proactively identify critical path activities, technical risks, resource needs, and budget implications; develop practical mitigation plans and contingency strategies in collaboration with internal and external teams.
- Provide technical leadership for CDMO evaluation, selection, onboarding, due diligence, technology transfer, and external development or manufacturing campaigns.
- Travel to global manufacturing and development sites as needed to support technical transfers, GMP campaigns, and troubleshooting.
Process Development &Scale-Up:
- Lead phase-appropriate drug substance and drug product development for clinical and late-stage programs, including formulation and process optimization, scale-up, and process characterization.
- Establish robust, scalable, reproducible, and cost-effective drug substance and drug product manufacturing processes capable of supporting clinical supply, regulatory submissions, and future commercial manufacture.
- Develop and maintain control strategies and ensure manufacturing processes, specifications, and technical packages are scientifically justified and aligned with global regulatory expectations.
- Serve as a technical subject matter expert through product registration, supporting technical assessments, development reports, process descriptions, control strategy documentation, and regulatory submission content.
- Lead technical troubleshooting, deviation investigations, root-cause analyses, CAPAs, change controls, batch record review, campaign data review in collaboration with Quality and external partners to support clinical supply.
- Review and approve key clinical CDMO technical documents, including protocols, batch records, campaign plans, development reports, deviation assessments, technical memos, and drug substance/drug product manufacturing documentation.
Regulatory and Commercial Readiness:
- Partner with Regulatory CMC to author, review, and defend technical content for INDs, NDAs, BLAs, MAAs, health authority questions, and briefing materials.
- Support MSAT team with PPQ planning and commercial technical readiness by ensuring drug substance and drug product process understanding, control strategy, comparability, and manufacturing documentation are appropriately developed for late-stage programs approaching filing and launch.
People Management:
- Lead, mentor, and develop internal technical development team members and matrixed project leads, fostering scientific rigor, accountability, collaboration, urgency, and pragmatic decision-making.
- Provide career development guidance, coaching, performance feedback, and succession planning for team members.
- Allocate resources effectively across programs and ensure technical development priorities are aligned with organizational objectives, program milestones, and available capacity.
- Build scalable technical development processes, templates, governance routines, and best practices appropriate for a growing biotech organization operating through external partners.
- Promote technical excellence through coaching, training, knowledge sharing, and transparent communication across internal teams and CDMO partners.
Requirements
- Advanced degree in chemistry, chemical engineering, pharmaceutical sciences, biochemistry, or a related scientific or engineering discipline; Ph.D. preferred.
- Strong understanding of small molecule, synthetic peptide, oligonucleotide, RNA, and/or amino acid chemistries and related manufacturing technologies.
- Minimum of 15 years of progressive pharmaceutical or biotechnology experience in technical development, process development, and late-stage CMC development including at least 5-8 years in a leadership capacity.
- Demonstrated expertise developing phase-appropriate processes across modalities from early clinical development through late-stage filing and commercialization.
- Deep expertise in Quality by Design (QbD), Advanced knowledge of cGMP expectations and relevant FDA, EMA, ICH, and other global CMC guidance and regulatory requirements.
- Strong track record supporting global CMC submissions, health authority interactions, inspection readiness, and successful product approvals preferred.
- Proven ability to operate independently, influence without direct authority, make sound technical decisions under ambiguity, and build trusted relationships with internal stakeholders and external partners.
- Excellent leadership, communication, collaboration, technical writing, and executive-level presentation skills.
- Ability to travel domestically and internationally up to 10%, with additional travel as business needs require.
Work Location and Conditions:
- At Amylyx, we proudly support remote work opportunities within the United States. However, due to business considerations candidates must be able to attend meetings at our office in Cambridge, MA on a regular basis. Preference will be given to candidates who reside in the New England region and can be in person on an as needed basis.
- When working remotly, you must have access to a work setting which enables meeting all requirements of the role (including privacy, reliable internet access, phone, ability to video conference, etc.) at your remote location.
Compensation
The pay range posted below represents our good faith estimate of compensation for this role, based on market data and internal benchmarks. The final offer may vary depending on a candidate’s experience, skills, and qualifications, as well as considerations of internal equity.
Base salary is one component of Amylyx’s total rewards package. In addition to competitive base pay, eligible employees may receive annual performance-based bonuses and equity awards, providing an opportunity to share in the company’s long-term success. Amylyx also offers a comprehensive benefits package designed to support the health, well-being, and financial security of our employees.
Estimated Pay Range
$247,000—$278,000 USD
To stay connected with us, follow Amylyx Pharmaceuticals on LinkedIn.
To return to our website please click here.
Amylyx Pharmaceuticals is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, or any other characteristic protected by applicable federal, state, or local laws and ordinances. Amylyx’s management team is dedicated to this policy with respect to recruitment, hiring, placement, promotion, transfer, training, compensation, benefits, employee activities, access to facilities and programs, and general treatment during employment. Accommodations are available for candidates who require them in our selection process. If you need an accommodation, please let your Amylyx Talent Acquisition contact know.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.

